speb/financial-data huggingface dataset:
Financial ratios for BYAH — annual report dated 2023-10-31
Total revenue: 336402.462380301
Gross profit: 293859.5075239398
Operating income: 161498.4952120383
Net income: 116558.41313269494
Capital expenditures: 3102.0519835841314
Operating cash flow: 17310.12311901505
Depreciation & amortization: 2744.5964432284545
Net tangible assets: 137355.54035567716
Owner earnings: 116200.95759233927
Return on net tangible assets (%): 84.59866801982733
Capex to operating income (%): 1.9207931191626983
Buffett classification: The Great
Shares outstanding: 5983216
Book value: 138505.19835841312
Debt to equity: 0.031074408897817526
Current ratio: 1.7508588770474258
Quick ratio: 1.6737248793549289
Effective tax rate (%): 27.888934120648052
COGS to revenue (%): 12.646445735069145
R&D to revenue (%): 1.2557836153197388
SG&A to revenue (%): 31.9047359564589
Free cash flow (dilution-adjusted): 14208.071135430917
Retained earnings: -14395.75923392613
Inventory turnover: 3.2438614790862625
Receivables turnover: 3.459732856109784
Capitalized R&D asset: 9831.324245483278
ROCI (R&D-adjusted, %): 107.9462220639855
Rosenberg metric: 11.871477799089577
FCF margin (%): 4.223533631382512
Revenue growth (%): 27.067408027095187
Rule of 40 score: 31.2909416584777
Financial ratios for BYAH — annual report dated 2024-10-31
Total revenue: 335000.14064697607
Gross profit: 307526.7229254571
Operating income: 111633.47398030941
Net income: 67308.15752461321
Capital expenditures: 12035.021097046412
Operating cash flow: 135087.2011251758
Depreciation & amortization: 3190.717299578059
Net tangible assets: 210754.43037974683
Owner earnings: 58463.85372714486
Return on net tangible assets (%): 27.740272705917523
Capex to operating income (%): 10.780835414267607
Buffett classification: The Great
Shares outstanding: 5983216
Book value: 211826.30098452885
Debt to equity: 0.04668926388616844
Current ratio: 1.8657485668629994
Quick ratio: 1.8188556813493102
Effective tax rate (%): 39.68385006194694
COGS to revenue (%): 8.201016772249817
R&D to revenue (%): 1.5414062424559722
SG&A to revenue (%): 49.38109058878998
Free cash flow (dilution-adjusted): 123052.18002812938
Retained earnings: 38226.16033755274
Inventory turnover: 2.7325070643202864
Receivables turnover: 2.146461451394296
Capitalized R&D asset: 10755.695924642572
ROCI (R&D-adjusted, %): 48.20787499705592
Rosenberg metric: 3.235236701696556
FCF margin (%): 36.731978616630514
Revenue growth (%): -0.4168583438427952
Rule of 40 score: 36.315120272787716
Financial ratios for BYAH — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 210754.43037974683
Buffett classification: The Gruesome
Shares outstanding: 5983216
Book value: 211826.30098452885
Debt to equity: 0.04668926388616844
Current ratio: 1.8657485668629994
Quick ratio: 1.8188556813493102
Retained earnings: 38226.16033755274
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HMR — annual report dated 2022-12-31
Total revenue: 31982848.936170213
Gross profit: 23390368.085106384
Operating income: 18007235.10638298
Net income: 17213775.531914894
Capital expenditures: 25715.957446808512
Operating cash flow: 15589457.446808511
Depreciation & amortization: 22445.744680851065
Net tangible assets: 23180923.40425532
Owner earnings: 17210505.319148935
Return on net tangible assets (%): 74.24426119275994
Capex to operating income (%): 0.1428090281205527
Buffett classification: The Great
Shares outstanding: 58991997
Book value: 23180923.404255316
Debt to equity: 1.0225086493534579
Current ratio: 1.5217569559211697
Quick ratio: 1.5217569559211697
Interest coverage ratio: 22.526088223669237
COGS to revenue (%): 26.865901997074364
SG&A to revenue (%): 16.831311649149193
Free cash flow (dilution-adjusted): 15589457.446808511
Retained earnings: 17213775.531914894
Receivables turnover: 2.3462219461297016
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 46.491879096841174
FCF margin (%): 48.74317943945888
Rule of 40 score: 48.74317943945888
Financial ratios for HMR — annual report dated 2023-12-31
Total revenue: 54552706.666666664
Gross profit: 33043347.777777776
Operating income: 21821441.111111112
Net income: 21726886.666666668
Capital expenditures: 10058.888888888889
Operating cash flow: 13360553.333333332
Depreciation & amortization: 14253.333333333332
Net tangible assets: 18233750
Owner earnings: 21731081.111111112
Return on net tangible assets (%): 119.18053670315274
Capex to operating income (%): 0.04609635467094367
Buffett classification: The Great
Shares outstanding: 58991997
Book value: 18233750
Debt to equity: 0.855577157743196
Current ratio: 1.312102941570276
Quick ratio: 1.2642385365278934
Interest coverage ratio: 14.299285883827979
COGS to revenue (%): 39.42858238055445
SG&A to revenue (%): 20.570760558657277
Free cash flow (dilution-adjusted): 13350494.444444444
Retained earnings: 11927941.11111111
Inventory turnover: 16.092846496153946
Receivables turnover: 4.315701526669044
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 88.72025664382204
FCF margin (%): 24.47265270634499
Revenue growth (%): 70.56862812797027
Rule of 40 score: 95.04128083431526
Financial ratios for HMR — annual report dated 2024-12-31
Total revenue: 30156117.708333336
Gross profit: 17698046.875
Operating income: 4260964.583333334
Net income: 1993178.125
Capital expenditures: 279622.9166666667
Operating cash flow: 7040940.625
Depreciation & amortization: 63068.75
Net tangible assets: 18178047.916666668
Owner earnings: 1776623.9583333333
Return on net tangible assets (%): 9.773458439970463
Capex to operating income (%): 6.562432313105942
Buffett classification: The Great
Shares outstanding: 58991997
Book value: 18974385.41666667
Debt to equity: 0.27828810880457805
Current ratio: 1.540194816848488
Quick ratio: 1.5090279395311719
Interest coverage ratio: 2.1415110736962024
COGS to revenue (%): 41.31191870858984
SG&A to revenue (%): 44.55839581748769
Free cash flow (dilution-adjusted): 6761317.708333334
Retained earnings: 13175622.916666668
Inventory turnover: 19.536804619669535
Receivables turnover: 3.1317460485737567
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.134915687908816
FCF margin (%): 22.421048271956153
Revenue growth (%): -44.7211338337505
Rule of 40 score: -22.300085561794347
Financial ratios for HMR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 18178047.916666668
Buffett classification: The Gruesome
Shares outstanding: 58991997
Book value: 18974385.41666667
Debt to equity: 0.27828810880457805
Current ratio: 1.540194816848488
Quick ratio: 1.5090279395311719
Retained earnings: 13175622.916666668
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INIO — annual report dated 2023-12-31
Total revenue: 2238888888.888889
Gross profit: 748222222.2222222
Operating income: 265222222.2222222
Net income: 87444444.44444445
Capital expenditures: 71111111.1111111
Operating cash flow: 165888888.8888889
Depreciation & amortization: 147222222.2222222
Owner earnings: 163555555.55555555
Capex to operating income (%): 26.811897779639715
Buffett classification: The Good
Shares outstanding: 750000000
Effective tax rate (%): 27.66544117647059
Interest coverage ratio: 1.782673637042569
COGS to revenue (%): 66.58064516129033
R&D to revenue (%): 4.153846153846154
SG&A to revenue (%): 17.419354838709676
Free cash flow (dilution-adjusted): 79000000
Capitalized R&D asset: 93000000
ROCI (R&D-adjusted, %): 351.8518518518518
FCF margin (%): 3.5285359801488836
Rule of 40 score: 3.5285359801488836
Financial ratios for INIO — annual report dated 2024-12-31
Total revenue: 2249062500
Gross profit: 803541666.6666667
Operating income: 310208333.3333334
Net income: 95833333.33333334
Capital expenditures: 71145833.33333334
Operating cash flow: 408333333.3333334
Depreciation & amortization: 151562500
Net tangible assets: -1606145833.3333335
Owner earnings: 176250000
Return on net tangible assets (%): -10.973474284973083
Capex to operating income (%): 22.934855607790464
Buffett classification: The Great
Shares outstanding: 750000000
Book value: 794479166.666667
Debt to equity: 2.5121279664350324
Current ratio: 1.155073105892778
Quick ratio: 0.7113424900310145
Effective tax rate (%): 13.20754716981132
Interest coverage ratio: 1.5486219448777954
COGS to revenue (%): 64.27215043305081
R&D to revenue (%): 4.154508823120745
SG&A to revenue (%): 18.06771339910148
Free cash flow (dilution-adjusted): 318125000
Retained earnings: -45833333.333333336
Inventory turnover: 3.4640539191213184
Receivables turnover: 9.945186549976968
Capitalized R&D asset: 155747500
ROCI (R&D-adjusted, %): 10.604157512882578
Rosenberg metric: 0.5948327359617692
FCF margin (%): 14.144782548284008
Revenue growth (%): 0.4544044665012431
Rule of 40 score: 14.599187014785251
Financial ratios for INIO — quarterly report dated 2025-03-31
Total revenue: 536956521.7391304
Gross profit: 205869565.21739128
Operating income: 81413043.47826086
Net income: 38043478.26086956
Capital expenditures: 24673913.043478258
Operating cash flow: 26195652.173913043
Depreciation & amortization: 38152173.91304348
Owner earnings: 51521739.130434774
Capex to operating income (%): 30.307076101468628
Buffett classification: The Good
Shares outstanding: 750000000
Effective tax rate (%): 25.531914893617024
Interest coverage ratio: 2.6280701754385962
COGS to revenue (%): 61.659919028340084
R&D to revenue (%): 3.906882591093117
SG&A to revenue (%): 19.63562753036437
Free cash flow (dilution-adjusted): -3043478.260869565
Capitalized R&D asset: 20978260.869565215
ROCI (R&D-adjusted, %): 454.7495682210708
FCF margin (%): -0.5668016194331984
Rule of 40 score: -0.5668016194331984
Financial ratios for INIO — annual report dated 2025-12-31
Total revenue: 3102117647.0588236
Gross profit: 1072705882.3529412
Operating income: 407647058.8235294
Net income: 169764705.88235295
Capital expenditures: 177647058.82352942
Operating cash flow: 644588235.2941177
Depreciation & amortization: 180588235.29411766
Net tangible assets: -2642470588.2352943
Owner earnings: 172705882.35294122
Return on net tangible assets (%): -6.5357731178487155
Capex to operating income (%): 43.57864357864358
Buffett classification: The Good
Shares outstanding: 750000000
Book value: 268352941.1764698
Debt to equity: 11.960105217010119
Current ratio: 1.3038232301206572
Quick ratio: 0.8668411106265446
Effective tax rate (%): 23.018458197611295
Interest coverage ratio: 2.117970660146699
COGS to revenue (%): 65.4202063106796
R&D to revenue (%): 3.9252123786407767
SG&A to revenue (%): 17.714654126213592
Free cash flow (dilution-adjusted): 443176470.5882353
Retained earnings: 118000000
Inventory turnover: 2.869261477045908
Receivables turnover: 8.789333333333333
Capitalized R&D asset: 215057830.88235295
ROCI (R&D-adjusted, %): 9.776954418647247
Rosenberg metric: 2.8806872581808634
FCF margin (%): 14.286256067961164
Revenue growth (%): 37.92936599400077
Rule of 40 score: 52.21562206196193
Financial ratios for IPX — annual report dated 2021-06-30
Total revenue: 0
Operating income: -8087294
Net income: -13230837
Capital expenditures: 571568
Operating cash flow: -3558025
Depreciation & amortization: 9324
Net tangible assets: 1760120
Owner earnings: -13793081
Return on net tangible assets (%): -783.6443537940595
Buffett classification: The Gruesome
Shares outstanding: 36213407
Book value: 1760120
Debt to equity: 0.270238392836852
Current ratio: 2.742971515584405
Quick ratio: 2.742971515584405
Interest coverage ratio: -2611.3316112366806
Free cash flow (dilution-adjusted): -8214357
Retained earnings: -13230837
Receivables turnover: 0
Capitalized R&D asset: 240000
ROCI (R&D-adjusted, %): -331.0393758132651
Rule of 40 score: 0
Financial ratios for IZM — annual report dated 2021-06-30
Total revenue: 43244709.90712074
Gross profit: 1241684.520123839
Operating income: 565345.9752321981
Net income: 407827.55417956656
Capital expenditures: 3367.6470588235293
Operating cash flow: 638947.0588235294
Depreciation & amortization: 30170.123839009288
Net tangible assets: 1071634.2105263157
Owner earnings: 434630.0309597523
Return on net tangible assets (%): 40.55768532681416
Capex to operating income (%): 0.595678965865172
Buffett classification: The Great
Shares outstanding: 8188610
Book value: 1147568.5758513939
Debt to equity: 2.284810947037975
Current ratio: 1.085231898527073
Quick ratio: 1.054475767882313
Effective tax rate (%): 28.861633740963466
Interest coverage ratio: 4.2236301754037
COGS to revenue (%): 97.1287019318879
R&D to revenue (%): 0.085219536113485
SG&A to revenue (%): 1.41827902527751
Free cash flow (dilution-adjusted): 546880.6501547988
Retained earnings: -1449641.4860681114
Inventory turnover: 110.14548369877387
Receivables turnover: 4.012585571875995
Capitalized R&D asset: 36852.94117647059
ROCI (R&D-adjusted, %): 49.80613693708338
FCF margin (%): 1.2646186119166185
Rule of 40 score: 1.2646186119166185
Financial ratios for IZM — annual report dated 2022-06-30
Total revenue: 43339756.86567164
Gross profit: 1166337.9104477612
Operating income: 557186.8656716418
Net income: 558860
Capital expenditures: 2854.0298507462685
Operating cash flow: 20679.10447761194
Depreciation & amortization: 28364.02985074627
Net tangible assets: 1509936.8656716417
Owner earnings: 584370
Return on net tangible assets (%): 38.701618146137776
Capex to operating income (%): 0.5122213078920976
Buffett classification: The Great
Shares outstanding: 8188610
Book value: 1566405.2238805965
Debt to equity: 1.1980129424583243
Current ratio: 1.123903455507023
Quick ratio: 1.119255275083758
Effective tax rate (%): -18.60183726385661
Interest coverage ratio: 10.46803355915474
COGS to revenue (%): 97.3088498994982
R&D to revenue (%): 0.1825713291251236
SG&A to revenue (%): 1.2248909881169359
Free cash flow (dilution-adjusted): 7834.626865671641
Retained earnings: -1057532.8358208954
Inventory turnover: 772.8400284452225
Receivables turnover: 3.734981486863031
Capitalized R&D asset: 103817.44073748903
ROCI (R&D-adjusted, %): 34.30983793086714
Rosenberg metric: -2.044520932950234
FCF margin (%): 0.01807722846705044
Revenue growth (%): 0.21978863716518915
Rule of 40 score: 0.2378658656322396
Financial ratios for LEGT — annual report dated 2023-11-30
Capital expenditures: 0
Net tangible assets: 7868
Buffett classification: The Gruesome
Shares outstanding: 22565984
Book value: 7868
Debt to equity: 1.588713777325877
Current ratio: 1.2624221629177785
Quick ratio: 1.2624221629177785
Retained earnings: -17632
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LEGT — quarterly report dated 2024-11-30
Total revenue: 0
Operating income: -164320
Net income: 2430170
Capital expenditures: 0
Operating cash flow: -117429
Net tangible assets: 204870317
Owner earnings: 2430170
Return on net tangible assets (%): 1.1861991700827994
Buffett classification: The Gruesome
Shares outstanding: 22565984
Book value: 204870317
Debt to equity: 0
Free cash flow (dilution-adjusted): -117429
Retained earnings: -5096613
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.07754086471286496
Rule of 40 score: 0
Financial ratios for LEGT — annual report dated 2024-11-30
Total revenue: 0
Operating income: -670426
Net income: 8215998
Capital expenditures: 0
Operating cash flow: -844493
Net tangible assets: 204870317
Owner earnings: 8215998
Return on net tangible assets (%): 4.010340844056975
Buffett classification: The Gruesome
Shares outstanding: 22565984
Book value: 204870317
Debt to equity: 0
Free cash flow (dilution-adjusted): -844493
Retained earnings: -5096613
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.3163669167842454
Rule of 40 score: 0
Financial ratios for LEGT — quarterly report dated 2025-02-28
Total revenue: 0
Operating income: -308607
Net income: 1942553
Capital expenditures: 0
Operating cash flow: -248752
Net tangible assets: 206812870
Owner earnings: 1942553
Return on net tangible assets (%): 0.9392805196311043
Buffett classification: The Gruesome
Shares outstanding: 22565984
Book value: 206812870
Debt to equity: 0
Free cash flow (dilution-adjusted): -248752
Retained earnings: -5393998
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.14430556323203836
Rule of 40 score: 0
Financial ratios for LEGT — quarterly report dated 2025-05-31
Total revenue: 0
Operating income: -167068
Net income: 2110094
Capital expenditures: 0
Operating cash flow: -86153
Net tangible assets: 208922964
Owner earnings: 2110094
Return on net tangible assets (%): 1.0099866283727432
Buffett classification: The Gruesome
Shares outstanding: 22565984
Book value: 208922964
Debt to equity: 0
Free cash flow (dilution-adjusted): -86153
Retained earnings: -5528784
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.07735821734084448
Rule of 40 score: 0
Financial ratios for LEGT — quarterly report dated 2025-11-30
Total revenue: 0
Operating income: -294018
Net income: 1845865
Capital expenditures: 0
Operating cash flow: -238918
Net tangible assets: 212768214
Owner earnings: 1845865
Return on net tangible assets (%): 0.8675473489663262
Buffett classification: The Gruesome
Shares outstanding: 22565984
Book value: 212768214
Debt to equity: 0
Free cash flow (dilution-adjusted): -238918
Retained earnings: -6077059
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.13375887037704645
Rule of 40 score: 0
Financial ratios for LEGT — annual report dated 2025-11-30
Total revenue: 0
Operating income: -1038758
Net income: 7897897
Capital expenditures: 0
Operating cash flow: -785914
Net tangible assets: 212768214
Owner earnings: 7897897
Return on net tangible assets (%): 3.7119722215650124
Buffett classification: The Gruesome
Shares outstanding: 22565984
Book value: 212768214
Debt to equity: 0
Free cash flow (dilution-adjusted): -785914
Retained earnings: -6077059
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.4725666342710991
Rule of 40 score: 0
Financial ratios for LSL.V — annual report dated 2022-12-31
Total revenue: 6039705.882352941
Gross profit: -1597058.8235294116
Operating income: -4968382.352941176
Net income: -5927941.176470588
Capital expenditures: 733088.2352941176
Operating cash flow: -2326470.588235294
Depreciation & amortization: 769852.9411764705
Net tangible assets: -2713235.2941176468
Owner earnings: -5891176.470588235
Buffett classification: The Gruesome
Shares outstanding: 126729818
Book value: 3890441.176470589
Debt to equity: 2.807219807219807
Current ratio: 0.3782923050438973
Quick ratio: 0.12377345498364603
Interest coverage ratio: -5.328864353312303
COGS to revenue (%): 126.44265887509133
R&D to revenue (%): 8.14463111760409
SG&A to revenue (%): 46.61553445337229
Free cash flow (dilution-adjusted): -3059558.8235294116
Retained earnings: -7177941.176470588
Inventory turnover: 3.5123435914778494
Receivables turnover: 6.672623883021933
Capitalized R&D asset: 491911.7647058823
ROCI (R&D-adjusted, %): -38.568722116971216
FCF margin (%): -50.65741417092768
Rule of 40 score: -50.65741417092768
Financial ratios for NICU.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -23855.147058823528
Operating income: -16403238.970588233
Net income: -16154102.941176469
Capital expenditures: 233012.49999999997
Operating cash flow: -13358675.735294117
Depreciation & amortization: 23855.147058823528
Net tangible assets: 14705208.088235293
Owner earnings: -16363260.294117644
Return on net tangible assets (%): -111.27527197121987
Buffett classification: The Gruesome
Shares outstanding: 250826305
Book value: 14705208.088235293
Debt to equity: 0.003043389539410382
Current ratio: 1.5880610758931817
Quick ratio: 1.5880610758931817
Interest coverage ratio: -344.1911469744191
Free cash flow (dilution-adjusted): -14137122.058823528
Retained earnings: -11490059.558823528
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -107.6424511576661
Rule of 40 score: 0
Financial ratios for NICU.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -47031.0606060606
Operating income: -9559053.03030303
Net income: -7365059.848484848
Capital expenditures: 61949.242424242424
Operating cash flow: -7981616.666666666
Depreciation & amortization: 47031.0606060606
Net tangible assets: 18824810.606060605
Owner earnings: -7379978.030303029
Return on net tangible assets (%): -39.203464963026306
Buffett classification: The Gruesome
Shares outstanding: 250826305
Book value: 18824810.606060605
Debt to equity: 0.0016923990140349113
Current ratio: 2.601493609483581
Quick ratio: 2.601493609483581
Interest coverage ratio: -35.269314624329155
Free cash flow (dilution-adjusted): -9148134.848484848
Retained earnings: -19203303.03030303
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -49.10789691426204
Rule of 40 score: 0
Financial ratios for NICU.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: 0
Operating income: -13625174.825174825
Net income: -11376223.776223777
Capital expenditures: 12587.412587412588
Operating cash flow: -12454545.454545455
Depreciation & amortization: 58111.18881118881
Net tangible assets: 24505594.40559441
Owner earnings: -11330700
Return on net tangible assets (%): -46.23719715777758
Buffett classification: The Gruesome
Shares outstanding: 250826305
Book value: 24505594.405594405
Debt to equity: 0.0013126730017407188
Current ratio: 5.757617348339281
Quick ratio: 5.757617348339281
Interest coverage ratio: -112.6242774566474
Free cash flow (dilution-adjusted): -13575524.475524476
Retained earnings: -29102097.902097903
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -54.23068358940102
Rule of 40 score: 0
Financial ratios for NICU.V — quarterly report dated 2025-03-31
Total revenue: 3004195.8041958045
Gross profit: -199300.6993006993
Operating income: -3853846.153846154
Net income: 7719580.41958042
Capital expenditures: 0
Operating cash flow: -1838461.5384615385
Depreciation & amortization: 727972.027972028
Net tangible assets: 59172727.27272727
Owner earnings: 8447552.447552448
Return on net tangible assets (%): 14.276091092806412
Buffett classification: The Gruesome
Shares outstanding: 250826305
Book value: 59172727.27272727
Debt to equity: 0.17195126274862024
Current ratio: 3.6371194850476063
Quick ratio: 3.078986187474856
Effective tax rate (%): 0
Interest coverage ratio: -10.827111984282908
COGS to revenue (%): 106.63407821229049
SG&A to revenue (%): 70.55400372439478
Free cash flow (dilution-adjusted): -2183916.083916084
Retained earnings: -8753846.153846154
Inventory turnover: 0.5503363767419509
Receivables turnover: 0.6932386638696144
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.596835880901722
FCF margin (%): -72.69553072625698
Rule of 40 score: -72.69553072625698
Financial ratios for NICU.V — quarterly report dated 2025-06-30
Total revenue: 13478102.189781021
Gross profit: -1321167.8832116788
Operating income: -7486861.313868613
Net income: -6935036.496350365
Capital expenditures: 1518248.1751824815
Operating cash flow: -8437956.204379562
Depreciation & amortization: 2832846.715328467
Net tangible assets: 55432846.71532846
Owner earnings: -5620437.956204379
Return on net tangible assets (%): -10.139183334869573
Buffett classification: The Gruesome
Shares outstanding: 250826305
Book value: 55432846.715328455
Debt to equity: 0.19610760702105529
Current ratio: 2.4301590858167152
Quick ratio: 2.065426842930764
Interest coverage ratio: -9.594948550046773
COGS to revenue (%): 109.80232873002977
SG&A to revenue (%): 15.11508258868129
Free cash flow (dilution-adjusted): -10394160.583941605
Retained earnings: -16072262.773722626
Inventory turnover: 2.4910922717778594
Receivables turnover: 1.0331225871426175
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.263186964926815
FCF margin (%): -77.11887354454373
Revenue growth (%): 348.64260082371646
Rule of 40 score: 271.5237272791727
Financial ratios for NICU.V — quarterly report dated 2025-09-30
Total revenue: 11713669.064748202
Gross profit: -2228776.978417266
Operating income: -8515827.338129496
Net income: -7656115.107913669
Capital expenditures: 3046762.589928058
Operating cash flow: -7756115.107913669
Depreciation & amortization: 2324460.4316546763
Net tangible assets: 84880575.53956835
Owner earnings: -8378417.26618705
Return on net tangible assets (%): -9.870829943043125
Buffett classification: The Gruesome
Shares outstanding: 250826305
Book value: 84880575.53956836
Debt to equity: 0.12970402766476807
Current ratio: 3.229743427304403
Quick ratio: 2.975324675324675
Interest coverage ratio: -9.600162206001622
COGS to revenue (%): 119.02714654219383
SG&A to revenue (%): 16.938950988822015
Free cash flow (dilution-adjusted): -11653237.410071945
Retained earnings: -23497122.302158274
Inventory turnover: 2.412848605577689
Receivables turnover: 0.5533013898800421
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.536673182907568
FCF margin (%): -99.48409286328463
Revenue growth (%): -13.091109565637494
Rule of 40 score: -112.57520242892213
Financial ratios for NICU.V — quarterly report dated 2025-12-31
Total revenue: 18809489.05109489
Gross profit: 2040145.9854014597
Operating income: -4629197.080291971
Net income: -18932846.715328466
Capital expenditures: 1082481.7518248174
Operating cash flow: -7425547.445255474
Depreciation & amortization: 3055474.452554744
Net tangible assets: 72024817.51824817
Owner earnings: -16959854.01459854
Return on net tangible assets (%): -23.547236354054768
Buffett classification: The Gruesome
Shares outstanding: 250826305
Book value: 72024817.51824816
Debt to equity: 0.16111640351054993
Current ratio: 3.1479443300433148
Quick ratio: 2.970886884896684
Interest coverage ratio: -1.7529021558872306
COGS to revenue (%): 89.15363421164965
SG&A to revenue (%): 14.913267880010867
Free cash flow (dilution-adjusted): -9813868.613138687
Retained earnings: -42772992.70072992
Inventory turnover: 4.606777621816724
Receivables turnover: 0.973112797855066
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.826059677360972
FCF margin (%): -52.175094105320355
Revenue growth (%): 60.57726189056564
Rule of 40 score: 8.402167785245283
Financial ratios for NICU.V — annual report dated 2025-12-31
Total revenue: 47423357.66423357
Gross profit: -1518978.102189781
Operating income: -24244525.547445253
Net income: -12396350.364963504
Capital expenditures: 5691970.802919707
Operating cash flow: -25618978.10218978
Depreciation & amortization: 8420437.956204379
Net tangible assets: 72024817.51824817
Owner earnings: -9667883.211678833
Return on net tangible assets (%): -13.422988831911143
Buffett classification: The Gruesome
Shares outstanding: 250826305
Book value: 72024817.51824816
Debt to equity: 0.16111640351054993
Current ratio: 3.1479443300433148
Quick ratio: 2.970886884896684
Interest coverage ratio: -5.378947368421053
COGS to revenue (%): 103.20301677697398
SG&A to revenue (%): 19.12421117438818
Free cash flow (dilution-adjusted): -34278102.18978102
Retained earnings: -42772992.70072992
Inventory turnover: 13.445157409264086
Receivables turnover: 2.453457195725237
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.038248530990963
FCF margin (%): -72.28105279359704
Rule of 40 score: -72.28105279359704
Financial ratios for NMC.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -4726635.294117646
Net income: -3275911.0294117643
Capital expenditures: 0
Operating cash flow: -5233766.911764706
Net tangible assets: 945105.8823529411
Owner earnings: -3275911.0294117643
Return on net tangible assets (%): -346.6184149924067
Buffett classification: The Gruesome
Shares outstanding: 87343174
Book value: 945105.8823529412
Debt to equity: 0
Current ratio: 1.391840437719532
Quick ratio: 1.391840437719532
Free cash flow (dilution-adjusted): -5233766.911764706
Retained earnings: -3341255.147058823
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -500.1170114770831
Rule of 40 score: 0
Financial ratios for NMC.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -6817476.515151515
Net income: -4659550.757575758
Capital expenditures: 75757.57575757576
Operating cash flow: -7556465.151515151
Net tangible assets: 2412628.7878787876
Owner earnings: -4735308.333333334
Return on net tangible assets (%): -196.2717330210038
Buffett classification: The Gruesome
Shares outstanding: 87343174
Book value: 2412628.787878788
Debt to equity: 0
Current ratio: 1.8912776336459929
Quick ratio: 1.8912776336459929
Free cash flow (dilution-adjusted): -7869346.969696969
Retained earnings: -8102056.060606061
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -282.57461526625985
Rule of 40 score: 0
Financial ratios for SUNCLAY.NS — annual report dated 2023-03-31
Total revenue: 246766138.85505483
Gross profit: 100327649.20828259
Operating income: -2372716.1997563946
Net income: -13135200.974421438
Capital expenditures: 22769792.935444582
Operating cash flow: 15365408.03897686
Depreciation & amortization: 17524969.549330086
Net tangible assets: 94198538.3678441
Owner earnings: -18380024.360535935
Return on net tangible assets (%): -19.51200589627216
Buffett classification: The Gruesome
Shares outstanding: 22046162
Book value: 94287454.32399514
Debt to equity: 1.4298152693450457
Current ratio: 1.0238314647007627
Quick ratio: 0.49782419495213226
Interest coverage ratio: -0.3259160113769449
COGS to revenue (%): 59.3430242602236
SG&A to revenue (%): 5.275056146499173
Free cash flow (dilution-adjusted): -7472594.397076736
Retained earnings: 5628501.827040195
Inventory turnover: 2.925349165409509
Receivables turnover: 8.030242974354909
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.194754854458251
FCF margin (%): -3.0282089883758236
Rule of 40 score: -3.0282089883758236
Financial ratios for UNP.TO — annual report dated 2022-12-31
Total revenue: 18290441176.47059
Gross profit: 8238970588.235293
Operating income: 7291911764.705882
Net income: 5145588235.294117
Capital expenditures: 2661764705.882353
Operating cash flow: 6883823529.411764
Depreciation & amortization: 1651470588.235294
Net tangible assets: 8943382352.941175
Owner earnings: 4135294117.6470585
Return on net tangible assets (%): 46.23859245251994
Capex to operating income (%): 36.50297468992639
Buffett classification: The Good
Shares outstanding: 7915181067
Book value: 8943382352.94117
Debt to equity: 2.874044232508429
Current ratio: 0.7159420289855073
Quick ratio: 0.5817028985507245
Effective tax rate (%): 22.8615520282187
Interest coverage ratio: 7.802517702596381
COGS to revenue (%): 54.95477386934673
Free cash flow (dilution-adjusted): 4222058823.5294113
Retained earnings: 43299264705.88235
Inventory turnover: 18.448043184885293
Receivables turnover: 13.154415653093603
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.5479150327888
FCF margin (%): 23.083417085427133
Rule of 40 score: 23.083417085427133
Financial ratios for UNP.TO — annual report dated 2023-12-31
Total revenue: 18271969696.969696
Gross profit: 7976515151.515151
Operating income: 6880303030.30303
Net income: 4832575757.575757
Capital expenditures: 2731818181.8181815
Operating cash flow: 6347727272.727272
Depreciation & amortization: 1756060606.060606
Net tangible assets: 11203030303.030302
Owner earnings: 3856818181.8181815
Return on net tangible assets (%): 34.426562077360025
Capex to operating income (%): 39.70491081259634
Buffett classification: The Good
Shares outstanding: 7915181067
Book value: 11203030303.030296
Debt to equity: 2.3112658912631874
Current ratio: 0.8123775949862907
Quick ratio: 0.6668625146886017
Effective tax rate (%): 22.519130329163122
Interest coverage ratio: 6.777611940298508
COGS to revenue (%): 56.34561963597163
Free cash flow (dilution-adjusted): 3615909090.9090905
Retained earnings: 47040151515.15151
Inventory turnover: 18.2907133243607
Receivables turnover: 11.63482875060299
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.642246799729147
FCF margin (%): 19.78937766905759
Revenue growth (%): -0.10098979747221705
Rule of 40 score: 19.688387871585373
Financial ratios for UNP.TO — annual report dated 2024-12-31
Total revenue: 16958041958.041958
Gross profit: 7719580419.58042
Operating income: 6792307692.307693
Net income: 4718181818.181818
Capital expenditures: 2413986013.986014
Operating cash flow: 6535664335.664336
Depreciation & amortization: 1676923076.923077
Net tangible assets: 11811188811.188812
Owner earnings: 3981118881.1188807
Return on net tangible assets (%): 33.70633510953226
Capex to operating income (%): 35.53999794090394
Buffett classification: The Good
Shares outstanding: 7915181067
Book value: 11811188811.188812
Debt to equity: 1.9220248667850797
Current ratio: 0.7653216596878568
Quick ratio: 0.6189569851541683
Effective tax rate (%): 23.27723447805322
Interest coverage ratio: 7.654058313632782
COGS to revenue (%): 54.478350515463916
Free cash flow (dilution-adjusted): 4121678321.678322
Retained earnings: 45893706293.7063
Inventory turnover: 17.179453836150845
Receivables turnover: 12.803590285110877
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.550503514192856
FCF margin (%): 24.305154639175257
Revenue growth (%): -7.19094744966464
Rule of 40 score: 17.114207189510616
Financial ratios for UNP.TO — quarterly report dated 2025-03-31
Total revenue: 4214685314.6853147
Gross profit: 1909090909.0909092
Operating income: 1658041958.041958
Net income: 1137062937.062937
Capital expenditures: 633566433.5664335
Operating cash flow: 1545454545.4545455
Depreciation & amortization: 426573426.5734266
Net tangible assets: 11216083916.083916
Owner earnings: 930069930.06993
Return on net tangible assets (%): 8.29228754909907
Capex to operating income (%): 38.21172501054407
Buffett classification: The Good
Shares outstanding: 7915181067
Book value: 11216083916.083923
Debt to equity: 2.1138474967267276
Current ratio: 0.7295081967213114
Quick ratio: 0.6094503375120539
Effective tax rate (%): 23.55430183356841
Interest coverage ratio: 7.36335403726708
COGS to revenue (%): 54.703832752613245
SG&A to revenue (%): -0.21569603451136554
Free cash flow (dilution-adjusted): 911888111.888112
Retained earnings: 46468531468.53147
Inventory turnover: 4.413654618473895
Receivables turnover: 3.0671755725190835
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.807612012204914
FCF margin (%): 21.635971461755435
Rule of 40 score: 21.635971461755435
Financial ratios for UNP.TO — quarterly report dated 2025-06-30
Total revenue: 4491970802.919707
Gross profit: 2075912408.759124
Operating income: 1843065693.430657
Net income: 1369343065.6934307
Capital expenditures: 683211678.8321167
Operating cash flow: 1702919708.029197
Depreciation & amortization: 447445255.4744525
Net tangible assets: 11867153284.671532
Owner earnings: 1133576642.3357663
Return on net tangible assets (%): 9.552220445319227
Capex to operating income (%): 37.06930693069307
Buffett classification: The Good
Shares outstanding: 7915181067
Book value: 11867153284.671532
Debt to equity: 2.0885717800467463
Current ratio: 0.6483261004339739
Quick ratio: 0.5283632982021078
Effective tax rate (%): 18.893212278426287
Interest coverage ratio: 7.537313432835822
COGS to revenue (%): 53.78615534611636
Free cash flow (dilution-adjusted): 1019708029.1970803
Retained earnings: 49293430656.9343
Inventory turnover: 4.276485788113696
Receivables turnover: 3.2135770234986945
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.064451741677934
FCF margin (%): 22.70068248293793
Revenue growth (%): 6.579031826367704
Rule of 40 score: 29.279714309305632
Financial ratios for UNP.TO — quarterly report dated 2025-09-30
Total revenue: 4492086330.935252
Gross profit: 2087050359.7122304
Operating income: 1833812949.6402879
Net income: 1286330935.2517986
Capital expenditures: 683453237.410072
Operating cash flow: 1814388489.2086332
Depreciation & amortization: 444604316.54676265
Net tangible assets: 12448920863.309353
Owner earnings: 1047482014.3884894
Return on net tangible assets (%): 8.41423948220065
Capex to operating income (%): 37.269517457826595
Buffett classification: The Good
Shares outstanding: 7915181067
Book value: 12448920863.30935
Debt to equity: 1.8982894128525203
Current ratio: 0.7478927203065134
Quick ratio: 0.5980842911877393
Effective tax rate (%): 22.864538395168246
Interest coverage ratio: 7.795107033639144
COGS to revenue (%): 53.53939782190904
Free cash flow (dilution-adjusted): 1130935251.7985613
Retained earnings: 49281294964.02878
Inventory turnover: 4.274936061381075
Receivables turnover: 3.250390421655388
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.018793258391537
FCF margin (%): 25.176169122357468
Revenue growth (%): 0.0025718781491144162
Rule of 40 score: 25.178741000506584
Financial ratios for 153A.T — annual report dated 2022-12-31
Total revenue: 5788955.762864882
Gross profit: 3727091.4835991575
Operating income: 1638812.8197411979
Net income: 1880529.6418898588
Capital expenditures: 19312.36834185977
Operating cash flow: 1620704.1829671985
Depreciation & amortization: 23194.402648209452
Net tangible assets: 1439098.7059885648
Owner earnings: 1884411.6761962085
Return on net tangible assets (%): 130.94387955145464
Capex to operating income (%): 1.1784364943465349
Buffett classification: The Great
Shares outstanding: 6346400
Book value: 1439098.7059885645
Debt to equity: 1.3069503620252505
Current ratio: 2.4263162644622134
Quick ratio: 2.4263162644622134
Effective tax rate (%): -13.693633047385992
Interest coverage ratio: 72.65877251501
COGS to revenue (%): 35.617205653776374
Free cash flow (dilution-adjusted): 1601391.8146253387
Retained earnings: 1025315.9795365634
Receivables turnover: 19.228047378679598
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 49.36288339735092
FCF margin (%): 27.662878768187888
Rule of 40 score: 27.662878768187888
Financial ratios for 153A.T — annual report dated 2023-12-31
Total revenue: 7035247.118715973
Gross profit: 4337559.21657357
Operating income: 2091925.3340875343
Net income: 1841002.6161351905
Capital expenditures: 49211.624125008835
Operating cash flow: 2167468.005373683
Depreciation & amortization: 34921.8694760659
Net tangible assets: 3193502.0858375165
Owner earnings: 1826712.8614862475
Return on net tangible assets (%): 57.2009290235732
Capex to operating income (%): 2.352456051997391
Buffett classification: The Great
Shares outstanding: 6346400
Book value: 3193502.085837517
Debt to equity: 0.6664349273895898
Current ratio: 2.1571126111017946
Quick ratio: 2.1571126111017946
Effective tax rate (%): 11.397974600841193
Interest coverage ratio: 84.96869615163699
COGS to revenue (%): 38.3452178151649
Free cash flow (dilution-adjusted): 2118256.3812486744
Retained earnings: 2804617.1250795447
Receivables turnover: 19.439191169287877
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 42.1659839979021
FCF margin (%): 30.109196528625777
Revenue growth (%): 21.528776637849386
Rule of 40 score: 51.63797316647516
Financial ratios for 2597.HK — annual report dated 2022-12-31
Total revenue: 116342385.05747126
Gross profit: 28072557.47126437
Operating income: 15530459.770114943
Net income: 10915517.241379311
Capital expenditures: 323132.183908046
Operating cash flow: -16756465.51724138
Depreciation & amortization: 1928017.2413793104
Net tangible assets: 101547988.50574712
Owner earnings: 12520402.298850577
Return on net tangible assets (%): 12.329542399692125
Capex to operating income (%): 2.080635014617178
Buffett classification: The Great
Shares outstanding: 30440000
Book value: 102650574.71264368
Debt to equity: 0.19671550623698295
Current ratio: 3.4911231525319986
Quick ratio: 3.4799978397450895
Effective tax rate (%): 15.453083595678663
Interest coverage ratio: 18.63012754222682
COGS to revenue (%): 75.87073923454726
R&D to revenue (%): 5.64611240850492
SG&A to revenue (%): 2.3212303162855377
Free cash flow (dilution-adjusted): -17079885.057471264
Inventory turnover: 198.821359223301
Receivables turnover: 1.4697000497315584
Capitalized R&D asset: 6568821.839080459
ROCI (R&D-adjusted, %): 18.226930577770297
FCF margin (%): -14.680707335537324
Rule of 40 score: -14.680707335537324
Financial ratios for 2597.HK — annual report dated 2023-12-31
Total revenue: 128780590.71729957
Gross profit: 27516736.99015471
Operating income: 14354852.320675105
Net income: 10917158.93108298
Capital expenditures: 363291.13924050634
Operating cash flow: -7905766.526019691
Depreciation & amortization: 1253445.8509142052
Net tangible assets: 110313924.05063291
Owner earnings: 11807313.642756678
Return on net tangible assets (%): 10.703375611348253
Capex to operating income (%): 2.5307898062961116
Buffett classification: The Great
Shares outstanding: 30440000
Book value: 111074964.83825597
Debt to equity: 0.33092537698972957
Current ratio: 2.9237608744922325
Quick ratio: 2.916109814626176
Effective tax rate (%): 9.83222464237358
Interest coverage ratio: 12.245110977804439
COGS to revenue (%): 78.63285388202658
R&D to revenue (%): 4.425914397737078
SG&A to revenue (%): 1.614298351954392
Free cash flow (dilution-adjusted): -8269198.312236287
Inventory turnover: 234.37044270833337
Receivables turnover: 1.5044609848671562
Capitalized R&D asset: 10100829.338231727
ROCI (R&D-adjusted, %): 12.974723280747924
Rosenberg metric: -0.08461494233301767
FCF margin (%): -6.421152648995773
Revenue growth (%): 10.691035475750331
Rule of 40 score: 4.269882826754558
Financial ratios for 2597.HK — annual report dated 2024-12-31
Total revenue: 125699444.93424657
Gross profit: 27824749.750684932
Operating income: 15847552.469863014
Net income: 7334859.061643835
Capital expenditures: 43970.06301369864
Operating cash flow: -15640000
Depreciation & amortization: 830684.9315068494
Net tangible assets: 115197521.8630137
Owner earnings: 8121573.930136986
Return on net tangible assets (%): 7.050129029506986
Capex to operating income (%): 0.2774564911352441
Buffett classification: The Great
Shares outstanding: 30440000
Book value: 115048781.34246576
Debt to equity: 0.3684908743054134
Current ratio: 2.313690697698806
Quick ratio: 2.3106348620269737
Effective tax rate (%): 1.4784142221019452
Interest coverage ratio: 9.89709595394552
COGS to revenue (%): 77.86406315060496
R&D to revenue (%): 4.149036532745992
SG&A to revenue (%): 1.2998646233426583
Free cash flow (dilution-adjusted): -15664415.473972602
Retained earnings: 59315701.43150685
Inventory turnover: 370.9964593071326
Receivables turnover: 1.0416138136942148
Capitalized R&D asset: 11201838.631729413
ROCI (R&D-adjusted, %): 11.887010094732412
Rosenberg metric: 0.05403999327254485
FCF margin (%): -12.461801627021236
Revenue growth (%): -2.3925544726043055
Rule of 40 score: -14.85435609962554
Financial ratios for 2597.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 115197521.8630137
Buffett classification: The Gruesome
Shares outstanding: 30440000
Book value: 115048781.34246576
Debt to equity: 0.3684908743054134
Current ratio: 2.313690697698806
Quick ratio: 2.3106348620269737
Retained earnings: 59315701.43150685
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2597.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 120859196.63458857
Buffett classification: The Gruesome
Shares outstanding: 30440000
Book value: 120690052.30962345
Debt to equity: 0.3671745656772805
Current ratio: 2.3416197307514706
Quick ratio: 2.3325327174532102
Retained earnings: 63964177.22733613
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 5461.T — annual report dated 2022-03-31
Total revenue: 527774135.3876414
Gross profit: 88747746.2711031
Operating income: 45541714.473037206
Net income: 31568595.312243894
Capital expenditures: 5999016.55466317
Operating cash flow: -9736108.834617276
Depreciation & amortization: 19890181.937387314
Net tangible assets: 534043599.4099328
Owner earnings: 45459760.694968045
Return on net tangible assets (%): 8.512368792584864
Capex to operating income (%): 13.172575130466079
Buffett classification: The Great
Shares outstanding: 26789222
Book value: 541370267.1693165
Debt to equity: 0
Current ratio: 4.952910152571106
Quick ratio: 4.055000941796949
Effective tax rate (%): 30.776140855192242
Interest coverage ratio: 926.1666666666665
COGS to revenue (%): 83.18452149878104
SG&A to revenue (%): 4.552865727728691
Free cash flow (dilution-adjusted): -15792493.033928866
Retained earnings: 453302737.2561875
Inventory turnover: 5.618837843507447
Receivables turnover: 3.264345093268451
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.278214753902992
FCF margin (%): -2.992282488858523
Rule of 40 score: -2.992282488858523
Financial ratios for 7132.T — annual report dated 2022-03-31
Total revenue: 44194902.4750041
Gross profit: 13628356.007211933
Operating income: 1342550.4015735125
Net income: 2089534.5025405672
Capital expenditures: 2436412.0635961317
Operating cash flow: -3488067.5299131293
Depreciation & amortization: 212760.20324536963
Net tangible assets: 16903458.44943452
Owner earnings: -134117.35781019507
Return on net tangible assets (%): -0.793431463811962
Capex to operating income (%): 181.47639453539907
Buffett classification: The Gruesome
Shares outstanding: 460280
Book value: 17395164.72709392
Debt to equity: 0.11098589532064612
Current ratio: 2.65662244190376
Quick ratio: 1.537000379166994
Effective tax rate (%): 31.919648817375425
Interest coverage ratio: 376.5931034482758
COGS to revenue (%): 69.16304044273495
Free cash flow (dilution-adjusted): -4146844.779544337
Retained earnings: 16808613.34207507
Inventory turnover: 2.844810779641574
Receivables turnover: 8.80423112840975
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.319816247223534
FCF margin (%): -9.38308390179099
Rule of 40 score: -9.38308390179099
Financial ratios for 7132.T — annual report dated 2023-03-31
Total revenue: 47182057.05705706
Gross profit: 14114947.447447449
Operating income: 1412319.8198198199
Net income: 451516.51651651657
Capital expenditures: 54099.099099099105
Operating cash flow: -529647.1471471472
Depreciation & amortization: 187672.6726726727
Net tangible assets: 15787537.53753754
Owner earnings: 585090.0900900902
Return on net tangible assets (%): 3.7060250130771792
Capex to operating income (%): 3.830513339818521
Buffett classification: The Great
Shares outstanding: 460280
Book value: 16512545.045045048
Debt to equity: 0.2760481952251246
Current ratio: 2.4036426986987984
Quick ratio: 1.4596850700356396
Effective tax rate (%): 30.49703581292686
Interest coverage ratio: 149.53974562798092
COGS to revenue (%): 70.0840778722761
Free cash flow (dilution-adjusted): -1290953.4534534535
Retained earnings: 15849324.324324327
Inventory turnover: 3.23345096349305
Receivables turnover: 9.449123746060767
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.088393998832236
FCF margin (%): -2.7361110006126035
Revenue growth (%): 6.75904779684138
Rule of 40 score: 4.022936796228777
Financial ratios for 7132.T — annual report dated 2024-03-31
Total revenue: 43251406.497622825
Gross profit: 13285769.941891178
Operating income: 2151069.730586371
Net income: 964639.4611727417
Capital expenditures: 107157.9503433703
Operating cash flow: 2936720.8135235077
Depreciation & amortization: 113351.82250396197
Net tangible assets: 15457778.658214474
Owner earnings: 970833.3333333334
Return on net tangible assets (%): 6.280548808462977
Capex to operating income (%): 4.981612116970266
Buffett classification: The Great
Shares outstanding: 460280
Book value: 15564513.998943476
Debt to equity: 0.11855805251390486
Current ratio: 2.773730839987552
Quick ratio: 1.766352437866606
Effective tax rate (%): 30.63950203449864
Interest coverage ratio: 388.7326968973747
COGS to revenue (%): 69.2824557217084
Free cash flow (dilution-adjusted): 2470668.2514527207
Retained earnings: 14905011.885895405
Inventory turnover: 3.5491635447869174
Receivables turnover: 8.6427137886399
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.062893631559657
FCF margin (%): 5.712341982655554
Revenue growth (%): -8.330816426000496
Rule of 40 score: -2.618474443344942
Financial ratios for 7132.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 16670717.187281132
Buffett classification: The Gruesome
Shares outstanding: 460280
Book value: 16889263.202129148
Debt to equity: 0.2599233904594292
Current ratio: 2.491847963416262
Quick ratio: 1.5026233981980255
Retained earnings: 16321032.357473034
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 7132.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 16542714.877690148
Buffett classification: The Gruesome
Shares outstanding: 460280
Book value: 16728238.203448737
Debt to equity: 0.10165932911658934
Current ratio: 2.956322324561976
Quick ratio: 1.7702011389283898
Retained earnings: 16130904.959230049
Capitalized R&D asset: 0
Rule of 40 score: 0